SCHEMBL30315224

SCHEMBL30315224

CC(C)n1cnc2c(NCCN3CCNC3=O)nc(-c3cccnc3)nc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 1/20 0.48
▸ ADORA1 P30542 1/20 0.48
▸ IRAK1 P51617 1/20 0.47
▸ IRAK4 Q9NWZ3 1/20 0.47
▸ CDK1 P06493 10/20 0.47
▸ CCNB1 P14635 8/20 0.47
▸ CDK5 Q00535 8/20 0.47
▸ CDK5R1 Q15078 7/20 0.47
▸ CCNB2 O95067 6/20 0.47
▸ CCNB3 Q8WWL7 6/20 0.47
▸ CDK2 P24941 8/20 0.45
▸ CCNE1 P24864 5/20 0.45
▸ CCNA2 P20248 3/20 0.45
▸ CCNA1 P78396 3/20 0.45
▸ CCNE2 O96020 2/20 0.45
▸ CDK9 P50750 3/20 0.43
▸ CDK4 P11802 4/20 0.43
▸ MAPK1 P28482 4/20 0.43
▸ CDK7 P50613 4/20 0.43
▸ CCNH P51946 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2312592 1.00 ADORA2A (0.48) ADORA2AADORA1IRAK1IRAK4CDK1
SCHEMBL30315385 0.87 CDK1 (0.45) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL2312403 0.87 CDK1 (0.45) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL2315254 0.81 CDK2 (0.48) IRAK4CDK1CCNB1CDK5CDK5R1
SCHEMBL21017207 0.80 CDK2 (0.52) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL3499988 0.80 CDK1 (0.44) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL30315450 0.80 CDK1 (0.44) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL2313497 0.80 CDK2 (0.52) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL2310920 0.79 AHR (0.64) ADORA2AADORA1IRAK1IRAK4CDK1
SCHEMBL30315325 0.79 AHR (0.64) ADORA2AADORA1IRAK1IRAK4CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524604-B1 EXPANDED HEMATOPOIETIC STEM CELLS FROM CORD BLOOD AND THEIR THERAPEUTIC USE NOVARTIS AG (CH) 2023-03-29 — — EP disclosed
Send feedback